U.S. Bancorp (USB)

NYSEFinancialsBanks - RegionalSnapshot 2026-11-05

$59.75-2.10%

Close 2026-11-05 · 1-day change

Investment OutlookAs of Nov 5, 2026

What could strengthen or challenge U.S. Bancorp’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

+0.6%

+10% or more+5%0%−5%−10% or less

5.83 → 5.86 EPS · FY ending Dec 31, 2027 · 19 analysts

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

Change in the same fiscal period’s mean EPS estimate from Oct 6, 2026 to Nov 5, 2026: (new ÷ prior − 1). Contributor count changed from 17 to 19; this is not the number of analysts revising. The ±10% axis is a display range.

Price, analyst earnings & P/E reference

The EPS and P/E reference is not available for USB yet.

Measure / period	Management expectations	Analyst expectations

Management figures unavailable.

Current consensus figures unavailable.

What the Thesis Depends On

4 published thesis conditions, with dated milestones shown separately.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Increase quarterly dividend by ~3.8% in 2026	A supporting condition in U.S. Bancorp's published investment case. The stated target is quarterly dividend >= $0.54 starting Q3 2026.	Intact	Dividend cut or no increase in 2026	Dividend per share: $0.54 per share FY2026-Q3; GAAP. Published target: quarterly dividend >= $0.54 starting Q3 2026. Target period is not explicitly aligned with this observation. Nov 5, 20260.54 USD/share · source valueLast status assessment Nov 5, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2027 · fiscal year ending 2027-12-31 · fmp

FY2027 EPS$5.86

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Increase quarterly dividend by ~3.8% in 2026Dividend per share: $0.54 per share
Deliver EPS near $5.1 in FY26Published status: Under Pressure
Sustain revenue growth near 5% annuallyPublished status: Under Pressure

Next proof point

Jan 19, 2027

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

0.8%Typical daily move · historical

Downside history

-16.2%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

U.S. Bancorp outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 31, 2026

What kind of bet this is

USB is a large financial business with a growth and execution thesis, rather than a clear turnaround story. The thesis is intact, with recent performance strong and momentum improving, though earnings quality is still fragile.

What's priced into U.S. Bancorp

Valuation is broadly aligned with the evidence, and the model shows only a small expectations gap. USB trades at a slight premium to peers, but the evidence does not point to a highly fragile setup driven by expensive valuation and turbulent conditions together.

What the fundamentals likely do

Over the multi-year view, continued revenue growth, positive operating leverage, loan and deposit growth, and higher fee revenue would support the business trajectory. Near term, miss risk is assessed as low, but prior deep misses and recent peer misses warrant attention; a guidance cut would be a meaningful negative.

What U.S. Bancorp hinges on

The thesis depends on management sustaining growth and positive operating leverage while expanding fee revenue and priority lending and deposit relationships. Near term, a shift to Fed rate cuts could weigh on the sector, while continued strong results and higher guidance from sector peers could support momentum; the recent president transition is another development to monitor.

Bottom line

For the next 1 to 3 years, USB’s thesis rests on whether recent operating progress can continue despite fragile earnings quality and rate sensitivity. The evidence currently supports an intact, moderately confident view. Not investment advice.

Development preview · refreshed Nov 6, 2026Open Living FV detail

Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2027 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-07-24	$5.82	$33,058,168,633	16 / 10
2026-07-25	$5.82	$33,058,168,633	16 / 10
2026-07-26	$5.78	$33,210,397,859	19 / 12
2026-07-27	$5.82	$33,061,936,053	16 / 10
2026-07-28	$5.82	$33,061,936,053	16 / 10
2026-07-29	$5.82	$33,061,936,053	16 / 10
2026-07-30	$5.78	$33,210,397,859	19 / 12
2026-07-31	$5.82	$33,061,936,053	16 / 10
2026-08-01	$5.82	$33,061,936,053	16 / 10
2026-08-02	$5.78	$33,210,397,859	19 / 12
2026-08-03	$5.78	$33,210,397,859	19 / 12
2026-08-04	$5.82	$33,061,936,053	16 / 10
2026-08-05	$5.82	$33,061,936,053	16 / 10
2026-08-06	$5.82	$33,061,936,053	16 / 10
2026-08-08	$5.79	$33,241,535,350	19 / 12
2026-08-09	$5.79	$33,241,535,350	19 / 12
2026-08-10	$5.82	$33,061,936,053	16 / 10
2026-08-12	$5.82	$33,061,936,053	16 / 10
2026-08-13	$5.82	$33,061,936,053	16 / 10
2026-08-14	$5.82	$33,061,936,053	16 / 10
2026-08-15	$5.82	$33,061,936,053	16 / 10
2026-08-16	$5.82	$33,061,936,053	16 / 10
2026-08-17	$5.82	$33,061,936,053	16 / 10
2026-08-18	$5.82	$33,061,936,053	16 / 10
2026-08-19	$5.82	$33,061,936,053	16 / 10
2026-08-20	$5.82	$33,019,818,009	16 / 10
2026-08-21	$5.82	$33,019,818,009	16 / 10
2026-08-22	$5.82	$33,019,798,906	16 / 10
2026-08-23	$5.82	$33,019,798,906	16 / 10
2026-08-24	$5.82	$33,019,798,906	16 / 10
2026-08-25	$5.82	$33,019,798,906	16 / 10
2026-08-26	$5.82	$33,019,798,906	16 / 10
2026-08-27	$5.82	$33,019,798,906	16 / 10
2026-08-28	$5.82	$33,019,798,906	16 / 10
2026-08-29	$5.82	$33,019,798,906	16 / 10
2026-08-30	$5.82	$33,019,798,906	16 / 10
2026-08-31	$5.82	$33,019,798,906	16 / 10
2026-09-01	$5.82	$33,019,798,906	16 / 10
2026-09-02	$5.82	$33,019,798,906	16 / 10
2026-09-03	$5.82	$33,019,798,906	16 / 10
2026-09-04	$5.82	$33,019,798,906	16 / 10
2026-09-05	$5.82	$33,019,798,906	16 / 10
2026-09-06	$5.82	$33,019,798,906	16 / 10
2026-09-07	$5.82	$33,019,798,906	16 / 10
2026-09-08	$5.82	$33,019,798,906	16 / 10
2026-09-09	$5.82	$33,054,189,267	16 / 10
2026-09-10	$5.82	$33,054,190,644	16 / 10
2026-09-11	$5.82	$33,054,190,644	16 / 10
2026-09-12	$5.82	$33,054,190,644	16 / 10
2026-09-13	$5.82	$33,054,190,644	16 / 10
2026-09-14	$5.82	$33,054,190,644	16 / 10
2026-09-15	$5.82	$33,054,190,644	16 / 10
2026-09-16	$5.82	$33,054,190,644	16 / 10
2026-09-17	$5.82	$33,054,212,211	16 / 10
2026-09-18	$5.82	$33,054,212,211	16 / 10
2026-09-19	$5.82	$33,054,212,211	16 / 10
2026-09-20	$5.82	$33,054,212,211	16 / 10
2026-09-21	$5.82	$33,054,212,211	16 / 10
2026-09-22	$5.82	$33,054,212,211	16 / 10
2026-09-23	$5.82	$33,054,212,211	16 / 10
2026-09-24	$5.83	$33,088,619,709	16 / 10
2026-09-25	$5.83	$33,092,858,598	16 / 10
2026-09-26	$5.83	$33,073,550,104	16 / 10
2026-09-27	$5.83	$33,094,997,601	16 / 10
2026-09-28	$5.83	$33,094,997,601	16 / 10
2026-09-29	$5.83	$33,103,028,758	16 / 10
2026-09-30	$5.83	$33,103,028,758	16 / 10
2026-10-01	$5.83	$33,127,173,858	17 / 10
2026-10-02	$5.83	$33,127,173,858	17 / 10
2026-10-03	$5.83	$33,135,248,516	17 / 10
2026-10-04	$5.83	$33,135,248,516	17 / 10
2026-10-05	$5.83	$33,137,217,683	17 / 10
2026-10-06	$5.83	$33,137,217,683	17 / 10
2026-10-07	$5.82	$33,141,844,507	17 / 10
2026-10-08	$5.83	$33,156,081,679	17 / 10
2026-10-09	$5.84	$33,172,340,537	18 / 11
2026-10-10	$5.84	$33,236,026,124	18 / 11
2026-10-11	$5.84	$33,236,026,124	18 / 11
2026-10-12	$5.84	$33,236,026,124	19 / 12
2026-10-13	$5.84	$33,236,026,124	19 / 12
2026-10-14	$5.84	$33,236,026,124	19 / 12
2026-10-15	$5.84	$33,236,031,679	19 / 12
2026-10-16	$5.85	$33,316,537,301	19 / 12
2026-10-17	$5.85	$33,316,537,301	19 / 12
2026-10-18	$5.86	$33,321,067,531	19 / 12
2026-10-19	$5.86	$33,321,067,531	19 / 12
2026-10-20	$5.85	$33,322,008,708	19 / 12
2026-10-21	$5.85	$33,322,008,708	19 / 12
2026-10-22	$5.85	$33,322,008,708	19 / 12
2026-10-23	$5.85	$33,322,008,708	19 / 11
2026-10-24	$5.85	$33,322,008,708	19 / 11
2026-10-25	$5.85	$33,322,008,708	19 / 11
2026-10-26	$5.85	$33,322,008,708	19 / 11
2026-10-27	$5.85	$33,322,008,708	19 / 11
2026-10-28	$5.86	$33,322,008,708	19 / 11
2026-10-29	$5.86	$33,322,008,708	19 / 11
2026-10-30	$5.86	$33,322,008,708	19 / 11
2026-10-31	$5.86	$33,341,915,128	19 / 11
2026-11-01	$5.86	$33,341,915,128	19 / 11
2026-11-02	$5.86	$33,341,915,128	19 / 11
2026-11-03	$5.86	$33,341,071,579	19 / 11
2026-11-04	$5.86	$33,341,071,579	19 / 11
2026-11-05	$5.86	$33,341,071,579	19 / 11

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold	Sell*
2026-06-01	12	10	1
2026-07-01	14	10	1
2026-08-01	14	9	0
2026-09-01	14	9	0
2026-10-01	16	9	0
2026-11-01	16	8	0

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 16 Buy / Strong Buy · 8 Hold · 0 Sell / Strong Sell

0 upgrades0 downgrades8 maintains

Recent actions · Oct 7–Nov 5 · 8 recorded

U.S. Bancorp (USB) Outlook: What's Priced In | QuarterlyIQ

What could strengthen or challenge U.S. Bancorp’s outlook?

Price, analyst earnings & P/E reference

What the Thesis Depends On

Incoming Evidence

Expectations trend

Outlook in Brief

What's improving

Still unresolved / key risks

Next proof point

Historical risk context

U.S. Bancorp outlook in detail

What kind of bet this is

What's priced into U.S. Bancorp

What the fundamentals likely do

What U.S. Bancorp hinges on

Bottom line

Analyst view

Price-target changes

Bottom line